Publications by authors named "Amber Atwater"

Claim this Profile
L
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis.
Andrew Blauvelt, Leon Kircik, Todd Schlesinger, Evangeline Pierce, Russel Burge, Amber Reck Atwater

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis.
Jenny E Murase, Kilian Eyerich, Raj Chovatiya, H Chih-Ho Hong, Christine Bangert, Amber Reck Atwater

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison Between Brazilian Propolis and Chinese Propolis: Results From the North American Contact Dermatitis Group 2019-2022.
Joel G DeKoven, Samuel J DeKoven, Erin M Warshaw, Amber Reck Atwater, Margo J Reeder

Dermatitis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paving the Way to Healthcare Equity: A Comprehensive Review of Care Gaps and Emerging Initiatives in Dermatology.
Andrew Alexis, Raj Chovatiya, Susan Taylor, Nada Elbuluk, Chesahna Kindred, Amber R Atwater

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities.
Ellen R Sher, Alexandra Golant, Marjolein de Bruin-Weller, Jose-Manuel Carrascosa, Vinay Mehta, Amber Reck Atwater

Ann Allergy Asthma Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of comprehensive patch testing: A call to action from the American Contact Dermatitis Society.
Jennifer K Chen, Amber Reck Atwater, Donald V Belsito, Alison Ehrlich, James S Taylor

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North American Contact Dermatitis Group Patch Test Results: 2021-2022.
Marie-Claude Houle, Joel G DeKoven, Amber Reck Atwater, Margo J Reeder, Erin M Warshaw

Dermatitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life.
Henriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, Detlef Becker, Philipp Bentz

J Eur Acad Dermatol Venereol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study.
Andrew Alexis, Ali Moiin, Jill Waibel, Paul Wallace, David Cohen, Amber Reck Atwater

Am J Clin Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated expert opinion guidelines regarding the effects of immunosuppressive agents on patch testing.
Mykayla Sandler, Brandon L Adler, Amber R Atwater, Donald V Belsito, Nina C Botto

J Am Acad Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials.
Emma Guttman-Yassky, David Rosmarin, Marjolein de Bruin-Weller, Stephan Weidinger, Thomas Bieber, Amber Reck Atwater

J Am Acad Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toluene-2,5-Diamine Sulfate: Allergen of the Year 2025.
Amber Reck Atwater, Nina Botto

Dermatitis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Impact of Atopic Dermatitis on Pediatric and Adolescent Patients With Moderate-To-Severe Disease: Results of a Real-World, Cross-Sectional Survey.
Lawrence F Eichenfield, Vivian Y Shi, JiaDe Yu, Evangeline J Pierce, Amber Reck Atwater

Pediatr Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patch Testing to (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020).
Erin M Warshaw, Malina Yamashita Peterson, Joel G DeKoven, Brandon L Adler, Melanie D Pratt, Amber R Atwater

Dermatitis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplifying Allergic Contact Dermatitis Management with the Contact Allergen Management Program 2.0.
Sarah Kamsiah Zemlok, Solbie Choi, Amber R Atwater, Margo J Reeder, Brandon L Adler

Cutis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final clinical diagnosis in cases of histopathologic psoriasiform dermatitis: retrospective cross-sectional analysis of a Southeastern United States population, 2004-2017.
Jordan Maxwell Ward, Beiyu Liu, Cynthia L Green, Adam K Brys, Amy J Petty, Amber Reck Atwater

Arch Dermatol Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009-2020.
Vincent A DeLeo, Brandon L Adler, Donald V Belsito, Melanie D Pratt, Denis Sasseville, Amber R Atwater

Contact Dermatitis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occupational Contact Dermatitis in Construction Workers: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2020.
Margo J Reeder, Alexander Idrogo-Lam, Srikanth R Aravamuthan, Erin M Warshaw, Joel G DeKoven, Amber R Atwater

Dermatitis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series.
Amber Reck Atwater, Beiyu Liu, Rabina Walsh, Raina Bembry, Jordan Maxwell Ward

Dermatitis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmedical Adhesive Allergens: Retrospective Analysis of Cross-Sectional Data From the North American Contact Dermatitis® Group, 2001-2018.
Amber Reck Atwater, Raina Bembry, Cynthia L Green, Erin M Warshaw, Donald V Belsito

Dermatitis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis.
Eric L Simpson, Marjolein de Bruin-Weller, H Chih-Ho Hong, Delphine Staumont-Sallé, Andrew Blauvelt, Amber Reck Atwater

Dermatol Ther (Heidelb)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patch Testing With Nickel, Cobalt, and Chromium in Patients With Suspected Allergic Contact Dermatitis.
Jonathan I Silverberg, Nisha Patel, Erin M Warshaw, Joel G DeKoven, Donald V Belsito, Amber R Atwater

Dermatitis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020.
Margo J Reeder, Aman Nihal, Srikanth R Aravamuthan, Erin M Warshaw, Joel G DeKoven, Amber R Atwater

Dermatitis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020.
Margo J Reeder, Donglin Zhang, Srikanth R Aravamuthan, Erin M Warshaw, Joel G DeKoven, Amber R Atwater

J Am Acad Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.
Jonathan I Silverberg, Evangeline Pierce, Meghan Feely, Amber Reck Atwater, Amy Schrader

J Dermatolog Treat· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis